Clinical Trial Information A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of INS018_055 Administered Orally to Subjects with Idiopathic Pulmonary Fibrosis (IPF) Protocol Number: 16709 Status: Open Age Group: Adult Treatment Type: Treatment Secondary Protocol No.: INS018-055-004 Phase: II NCT ID: NCT05975983 Scope Information Scope: National Disease Site(s): Other
